En español
NIDA

Researchers

Journal Highlights Opportunities in Hispanic Drug Abuse Research

Reviews a journal supplement that compiles information on drug abuse research in the Hispanic population.

Videos Help Treat Deaf People

Reviews a training DVD that presents dialectical behavior therapy skills being taught by deaf clinicians to deaf consumers as an approach to improve deaf people's access to behavioral health care.

Vaccine May Reduce Fetal Exposure to Nicotine

Describes research on a vaccine developed to facilitate smoking cessation by blocking nicotine penetration into the brain.

Uneven Regional Brain Development Contributes to Adolescent Risk-Taking

Reports on the work of scientists who have linked impulsiveness and risk-taking among adolescents to immaturity of the brain region called the orbitofrontal cortex.

Latest Information on MDMA/Ecstasy, Steroids, and HIV/AIDS Is Available on NIDA's Web Site

Announces updates to research reports on MDMA/ecstasy and steroids and a new report on HIV/AIDS that provide the latest available information on drugs and drug-related topics.

Standard Treatments Help Depressed Smokers Quit

Describes a study comparing Staged Care Intervention, a combination treatment for smoking cessation, among smokers in outpatient treatment for depression and a control group.

Serotonin System May Have Potential as a Target for Cocaine Medications

Describes investigations to advance the development of potential drug abuse relapse prevention agents by targeting specific receptors of the neurochemical serotonin.

Antipsychotic Drug Prevents Morphine Tolerance in Mice

Summarizes animal studies indicating that an antipsychotic drug, trifluoperazine, prevents morphine tolerance in mice.

Scientists Pinpoint Brain's Sweet Tooth

Reports on research that successfully traced rats’ liking for sweets to a 1-cubic millimeter site in the medial shell of the nucleus accumbens in the brain.

Naltrexone-Nicotine Patch Combination Shows Promise

Reports findings from a clinical trial investigating the effectiveness of naltrexone as a supplement to nicotine replacement therapy for smoking cessation.

Pages